The content is available as a PDF (319.9 KB).
Bibliografía
- 1.Herdman M. La medición de la calidad de vida relacionada con la salud. Med Clin (Barc) 2000;114(Supl 3):22–25. [PubMed] [Google Scholar]
- 2.Badia X., Carné X. La evaluación de la calidad de vida en el contexto del ensayo clínico. Med Clin (Barc) 1998;110:550–556. [PubMed] [Google Scholar]
- 3.Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72. doi: 10.1016/0168-8510(96)00822-6. [DOI] [PubMed] [Google Scholar]
- 4.Kaplan R.M., Anderson J.P., Wu A.W., Mathews W.C., Kozin F., Orenstein D. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989;27(Supl 3):27–43. doi: 10.1097/00005650-198903001-00003. [DOI] [PubMed] [Google Scholar]
- 5.Feeny D., Furlong W., Boyle M., Torrance G.W. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490–502. doi: 10.2165/00019053-199507060-00004. [DOI] [PubMed] [Google Scholar]
- 6.Sintonen H. An approach to measuring and valuing health states. Soc Sci Med (Med Econ) 1981;15:55–65. doi: 10.1016/0160-7995(81)90019-8. [DOI] [PubMed] [Google Scholar]
- 7.Badia X., Roset M., Montserrat S., Herdman M., Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc) 1999;112(Supl 1):79–86. [PubMed] [Google Scholar]
- 8.Froberg D.G., Kane R.L. Methodology for measuring health-state preferences–II: Scaling methods. J Clin Epidemiol. 1989;42:459–471. doi: 10.1016/0895-4356(89)90136-4. [DOI] [PubMed] [Google Scholar]
- 9.Badia X., Roset M., Herdman M., Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001;21:7–16. doi: 10.1177/0272989X0102100102. [DOI] [PubMed] [Google Scholar]
- 10.Wu A.W., Jacobson D.L., Berzon R.A. The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Qual Life Res. 1997;6:3–10. doi: 10.1023/a:1026471020698. [DOI] [PubMed] [Google Scholar]
- 11.Bosch J.L., Hunink M.G. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res. 2000;9:591–601. doi: 10.1023/a:1008929129537. [DOI] [PubMed] [Google Scholar]
- 12.Suárez-Almazor M.E., Kendall C., Johnson J.A., Skeith K., Vincent D. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxford) 2000;39:783–790. doi: 10.1093/rheumatology/39.7.783. [DOI] [PubMed] [Google Scholar]
- 13.Paterson C., Langan C.E., McKaig G.A. Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and Euro-Qol (EQ-5D) Qual Life Res. 2000;9:521–527. doi: 10.1023/a:1008930521566. [DOI] [PubMed] [Google Scholar]
- 14.Fransen M., Edmonds J. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology (Oxford) 1999;38:807–813. doi: 10.1093/rheumatology/38.9.807. [DOI] [PubMed] [Google Scholar]
- 15.Kind P., Leeses B., Hardman G. Demonstrating the value of EQ-5D as a tool for monitoring health status in primary care. In: Rabin R., Busschbach J.J.V., De Charro F., Essink-Bot M.L., Bonsel G., editors. Proceedings of the 14th Plenary Meeting of the EuroQol Group. Erasmus University; Rotterdam: 1997. pp. 195–212. [Google Scholar]
- 16.Hare J., Leese B., Hardman G. Applications of EQ-5D in general practice: an exploratory study. In: Rabin R., Busschbach J.J.V., De Charro F., Essink-Bot M.L., Bonsel G., editors. Proceedings of the 14th Plenary Meeting of the EuroQol Group. Erasmus University; Rotterdam: 1997. pp. 175–193. [Google Scholar]
- 17.Schrag A., Selai C., Jahanshahi M., Quinn N.P. The EQ-5D—a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson´s disease. J Neurol Neurosurg Psychiatry. 2000;69:67–73. doi: 10.1136/jnnp.69.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Roset M., Badia X., Benavides A., Herdman M. The validity of the EQ-5D in children with asthma. In: Badia X., Herdman M., Roset M., editors. Proceedings of the 16th Plenary Meeting of the EuroQol Group. Institut Universitari de Salut Pública de Catalunya; Barcelona: 1999. pp. 13–26. [Google Scholar]
- 19.Badia X., Schiaffino A., Alonso J., Herdman M. Using the Euro-QoI 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res. 1998;7:311–322. doi: 10.1023/a:1024933913698. [DOI] [PubMed] [Google Scholar]
- 20.Roset M., Badia X., Mayo N.E. Sample size calculations in studies using the EuroQol 5D. Qual Life Res. 1999;8:539–549. doi: 10.1023/a:1008973731515. [DOI] [PubMed] [Google Scholar]
- 21.Badia Llach X., Herdman M., Schiaffino A. Determining correspondence between scores on the EQ-5D «thermometer» and a 5-point categorical rating scale. Med Care. 1999;37:671–677. doi: 10.1097/00005650-199907000-00007. [DOI] [PubMed] [Google Scholar]
- 22.Mehrez A., Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989;9:142–149. doi: 10.1177/0272989X8900900209. [DOI] [PubMed] [Google Scholar]
- 23.Johnson J.A., Pickard A.S. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care. 2000;38:115–121. doi: 10.1097/00005650-200001000-00013. [DOI] [PubMed] [Google Scholar]
- 24.Myers C., Wilks D. Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res. 1999;8:9–16. doi: 10.1023/a:1026459027453. [DOI] [PubMed] [Google Scholar]
- 25.EuroQol group EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9. [DOI] [PubMed] [Google Scholar]